Abstract
Barrier stabilizing effects of cAMP as well as of the small GTPase
Rac 1 are well established. Moreover, it is generally believed that
permeability-increasing mediators such as thrombin disrupt endothelial
barrier functions primarily via activation of Rho A. In this study,
we provide evidence that decrease of both cAMP levels and of Rac
1 activity contribute to thrombin-mediated barrier breakdown. Treatment
of human dermal microvascular endothelial cells (HDMEC) with Rac
1-inhibitor NSC-23766 decreased transendothelial electrical resistance
(TER) and caused intercellular gap formation. These effects were
reversed by addition of forskolin/rolipram (F/R) to increase intracellular
cAMP but not by the cAMP analogue 8-pCPT-2'-O-Methyl-cAMP (O-Me-cAMP)
which primarily stimulates protein kinase A (PKA)-independent signaling
via Epac/Rap 1. However, both F/R and O-Me-cAMP did not increase
TER above control levels in the presence of NSC-23766 in contrast
to experiments without Rac 1 inhibition. Because Rac 1 was required
for maintenance of barrier functions as well as for cAMP-mediated
barrier stabilization, we tested the role of Rac 1 and cAMP in thrombin-induced
barrier breakdown. Thrombin-induced drop of TER and intercellular
gap formation were paralleled by a rapid decrease of cAMP as revealed
by fluorescence resonance energy transfer (FRET). The efficacy of
F/R or O-Me-cAMP to block barrier-destabilizing effects of thrombin
was comparable to Y27632-induced inhibition of Rho kinase but was
blunted when Rac 1 was inactivated by NSC-23766. Taken together,
these data indicate that decrease of cAMP and Rac 1 activity may
be an important step in inflammatory barrier disruption.
Users
Please
log in to take part in the discussion (add own reviews or comments).